Ligand Pharmaceuticals Incorporated Financial Ratios — LGND

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.75	13.59	-7.41	10.93	-0.8	22.48
Return on Assets (%)	9.91	-0.47	10.93	6.63	60.39	-0.3	1.97	14.84	45.67	-0.21	4.3	-3.24	6.73	-0.47	9.95
Return on Capital (%)	- -	- -	-1.73	-2.33	- -	2.9	-8.96	146.82	90.23	- -	- -	-5.12	10.06	-1.75	16.37
Return on Invested Capital (%)	- -	- -	26.29	14.2	- -	-2.31	2.34	14.56	-0.35	- -	- -	-0.05	1.19	-4.75	3.19
Gross Margin (%)	83.66	88.53	88.3	85.84	91.93	94.89	96.2	97.48	90.57	81.4	74.26	73.08	91.99	93.37	94.57
EBITDA Margin (%)	10.13	12.56	38.07	36.21	41.66	50.63	56.55	70.97	31.6	29.56	64.09	27.81	35.29	34.86	30.2
Operating Margin (%)	0.85	3.87	32.64	32.09	38	40.27	48.25	65.11	-4.76	12.46	42.99	1.55	7.48	13.77	17.61
Incremental Operating Margin (%)	178.67	71.13	83.98	30.37	89.74	44.67	75.29	86.68	- -	60.32	107.03	222.55	-10.45	36.85	23.95
Pretax Margin (%)	-11.85	-12.31	18.8	17.51	49.13	7.3	40.56	68.93	662.31	0.79	29.89	18.35	48.48	1.51	59.29
Profit Margin (%)	32.34	-1.68	23.32	18.63	319.58	-1.5	8.9	57	523.19	-1.82	23.66	-17	39.72	-2.41	46.42
Net Income to Common Margin (%)	32.34	-1.68	23.32	18.63	319.58	-1.5	8.9	57	523.19	-1.82	23.66	-17	39.72	-2.41	46.42
Effective Tax Rate (%)	- -	- -	4.06	3.63	- -	129.74	78.06	17.31	21.01	- -	- -	114.49	15.46	260.13	21.71
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.75	13.59	-7.41	10.93	-0.8	22.48

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	30	28	9	196	242	242	243	636	650	456	324	88	6	7	451
ST Debt	10	15	9	- -	202	213	225	26	1	8	1	77	- -	1	1
LT Debt	20	13	- -	196	40	30	19	610	649	448	323	10	6	6	450
Total Debt/EBITDA	9.95	7.17	0.49	8.4	8.07	4.39	3.05	3.57	17.11	9.44	2.1	1.61	0.13	0.12	5.58
Net Debt/EBITDA	7.64	4.03	-0.14	1.54	4.81	4.05	2.79	2.91	14.93	8.16	1.95	0.58	-0.5	-1.24	3.35
Total Debt/EBIT	119.24	23.27	0.57	9.48	8.84	5.53	3.58	3.89	-113.65	22.39	3.12	28.89	0.63	0.31	9.57
Net Debt/EBIT	91.52	13.08	-0.16	1.74	5.28	5.1	3.27	3.17	-99.18	19.36	2.9	10.43	-2.34	-3.14	5.75
EBITDA to Interest Expense	1.21	- -	- -	- -	- -	4.3	5.93	3.7	1.06	1.76	7.89	30.33	70.64	19.18	17.17
EBITDA-CapEx/Interest Expense	0.04	- -	- -	- -	- -	2.77	5.77	3.47	0.99	1.6	7.44	20.37	-11.44	12.72	14.77
EBIT to Interest Expense	0.1	- -	- -	- -	- -	3.42	5.06	3.39	-0.16	0.74	5.29	1.69	14.97	7.58	10.01
Interest Expense	3	- -	- -	- -	- -	13	13	48	36	27	20	2	1	3	5
Common Equity/Total Assets	-565.76	-654.84	-641.1	-255.51	-85.37	-71.66	-59.75	-18.18	26.77	28.77	34.61	59.12	63.9	52.99	38.97
Long-Term Debt/Equity (%)	247.84	50.76	- -	802.64	14.31	7.97	4.5	108.73	84.58	63.13	39.33	1.73	0.82	0.7	44.28
Long-Term Debt/Capital (%)	-3.11	-2.05	- -	-42.13	-21.09	-15.67	-11.97	149.8	61.78	52.8	41.76	1.92	1.13	1.15	42.51
Long-Term Debt/Total Assets (%)	16.82	12.89	- -	75.92	7.88	4.91	2.81	48.37	43.41	32.88	24.89	1.36	0.73	0.62	28.86
Total Debt/Equity (%)	370.02	106.77	18.36	804.01	87.25	65.38	58.14	113.44	84.74	64.33	39.5	14.69	0.88	0.85	44.39
Total Debt/Capital (%)	-4.65	-4.32	-1.38	-42.21	-128.61	-128.54	-154.52	156.29	61.9	53.8	41.94	16.29	1.21	1.4	42.61
Total Debt/Total Assets (%)	25.12	27.12	8.7	76.05	48.03	40.31	36.27	50.47	43.49	33.5	25	11.51	0.78	0.75	28.93
Net Debt to Equity	284	60.02	-5.1	147.65	52.07	60.33	53.21	92.55	73.96	55.63	36.68	5.3	-3.27	-8.71	26.67
Net Debt/Capital (%)	-3.53	-2.38	0.38	-5.76	-50.54	-107.88	-125.06	179.04	57.97	49.29	39.95	6.42	-4.72	-16.67	30.66
EBITDA	3	4	19	23	30	55	80	178	38	48	155	55	46	58	81
EBITDA-CapEx	- -	-5	14	19	19	36	78	168	35	44	146	37	-8	39	70
Operating Income (Loss)	- -	1	16	21	27	44	68	164	-6	20	104	3	10	23	47

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.39	0.35	0.55	7.35	0.9	0.62	0.84	9.41	62.93	4.11	8.19	2.14	10.15	7.17	20.2
Current Ratio	0.74	0.67	0.86	8.13	0.96	0.72	0.99	10.58	66.09	5	11.15	2.67	14.15	8.93	22.23
Quick Ratio	0.68	0.6	0.78	7.94	0.95	0.7	0.97	10.09	65.38	4.7	10.39	2.5	12.49	8.32	21.83
CFO/Avg Current Liab	-0.03	- -	0.64	0.8	0.34	0.27	0.38	1.21	-0.59	0.93	1.11	1.96	0.86	3.6	1.32
Common Equity/Total Assets	-565.76	-654.84	-641.1	-255.51	-85.37	-71.66	-59.75	-18.18	26.77	28.77	34.61	59.12	63.9	52.99	38.97
Long-Term Debt/Equity (%)	247.84	50.76	- -	802.64	14.31	7.97	4.5	108.73	84.58	63.13	39.33	1.73	0.82	0.7	44.28
Long-Term Debt/Capital (%)	-3.11	-2.05	- -	-42.13	-21.09	-15.67	-11.97	149.8	61.78	52.8	41.76	1.92	1.13	1.15	42.51
Long-Term Debt/Total Assets (%)	16.82	12.89	- -	75.92	7.88	4.91	2.81	48.37	43.41	32.88	24.89	1.36	0.73	0.62	28.86
Total Debt/Equity (%)	370.02	106.77	18.36	804.01	87.25	65.38	58.14	113.44	84.74	64.33	39.5	14.69	0.88	0.85	44.39
Total Debt/Capital (%)	-4.65	-4.32	-1.38	-42.21	-128.61	-128.54	-154.52	156.29	61.9	53.8	41.94	16.29	1.21	1.4	42.61
Total Debt/Total Assets (%)	25.12	27.12	8.7	76.05	48.03	40.31	36.27	50.47	43.49	33.5	25	11.51	0.78	0.75	28.93
CFO/Total Liabilities	-1.04	0.21	37.55	8.8	18.45	26.32	35.09	27.73	-4.03	8.36	16.54	83.45	57.45	87.17	9.08
CFO/CapEx	-0.4	0.02	4.19	4.57	3.84	3.11	41.08	17.82	-11.49	12.24	8.99	7.69	0.92	4.94	4.36
Altman's Z-Score	-17.98	-23.89	-16.96	-1.38	2.52	2.01	3.68	3.07	2.72	3.15	4.16	7.49	11.54	12.83	5.84

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	8.46	5.87	14.38	8.69	7.65	10.44	7	6.17	2.79	3.75	3.39	3.39	4.15	4.69	5.47
Days Sales Outstanding	43.16	62.21	25.38	42.01	47.72	34.95	52.12	59.11	130.84	97.33	107.52	107.76	88.03	77.85	66.7
Inventory Turnover	7.55	2.4	3.71	11	6.11	3.13	1.7	1.1	1.57	1.8	2.31	2.6	0.56	0.58	1.25
Days Inventory Outstanding	48.37	151.94	98.35	33.18	59.78	116.49	214.13	331.1	231.92	202.68	157.95	140.33	646.93	627.61	291.52
Accounts Payable Turnover	0.63	0.47	1.11	1.38	1.22	1.72	3.13	2.82	3.49	15.99	10.34	5.66	5.48	0.32	2.26
Accounts Payable Turnover Days	577.83	772.51	329.72	265.31	299.82	212.27	116.58	129.36	104.61	22.82	35.3	64.49	66.62	1,146.8	161.69
Cash Conversion Cycle	-486.31	-558.36	-205.99	-190.12	-192.33	-60.83	149.66	260.85	258.16	277.19	230.17	183.6	668.34	-441.34	196.52
Inventory to Cash Days	-5.21	-89.73	-72.97	8.83	-12.06	-81.54	-162.01	-271.99	-101.08	-105.35	-50.44	-32.57	-558.9	-549.76	-224.82
Inventories	1	2	1	- -	2	2	4	7	7	26	27	13	24	14	9
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	1	2	1	- -	2	2	4	7	7	26	27	13	24	14	9

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	145	257	666	678	1,339	1,321	1,797	1,791	1,236	1,004	1,602	1,127	1,235	1,960	3,656
- Cash & Cash Equivalents	7	12	12	160	97	19	21	117	72	48	20	45	23	72	175
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	-2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	30	28	9	196	242	242	243	636	650	456	324	88	6	7	451
Enterprise Value	159	273	660	705	1,380	1,422	1,838	1,654	816	1,049	1,586	1,003	1,071	1,701	3,351
Total Capital	-652	-654	-662	-465	-188	-189	-158	407	1,050	848	773	539	509	506	1,060
Total Debt/Capital (%)	-4.65	-4.32	-1.38	-42.21	-128.61	-128.54	-154.52	156.29	61.9	53.8	41.94	16.29	1.21	1.4	42.61
Total Debt / EV	0.19	0.1	0.01	0.28	0.18	0.17	0.13	0.38	0.8	0.43	0.2	0.09	0.01	- -	0.13
EV/Sales	5.28	8.69	13.47	10.92	19.19	13.05	13.03	6.58	6.79	6.42	6.57	5.11	8.16	10.18	12.5
EV/EBITDA	52.13	69.2	35.37	30.16	46.07	25.77	23.04	9.27	21.47	21.7	10.24	18.37	23.12	29.19	41.39
EV/EBIT	624.79	224.52	41.27	34.03	50.5	32.4	27	10.1	- -	51.47	15.27	330.15	109.08	73.87	71.01
EV/Cash Flow to Firm	- -	1,694.39	31.88	34.26	33.07	24.98	20.09	7.07	- -	5.39	15.93	7.29	21.37	18.45	63.17
EV/Free Cash Flow to Firm	- -	30.98	25.74	28.11	26.24	18.6	19.62	6.75	561.44	5.27	14.64	6.45	10.3	15.21	52.07
Diluted Market Cap	146	257	681	711	1,436	1,321	2,006	2,037	1,285	1,004	1,662	1,127	1,268	1,960	3,837
Diluted Enterprise Value	169	273	678	745	1,580	1,544	2,228	2,556	1,864	1,413	1,967	1,170	1,251	1,895	4,114
EV per Share	8.07	13.74	32.47	34.51	69.73	68.26	87.4	78.15	42.97	64.83	95.35	59.44	61.93	92.98	173.31
TTM Sales	30	31	49	65	72	109	141	251	120	164	242	196	131	167	268
TTM EBITDA	3	4	19	23	30	55	80	178	38	48	155	55	46	58	81
TTM Operating Income	- -	1	16	21	27	44	68	164	-6	20	104	3	10	23	47
TTM Cash Flow to Firm	-8	- -	21	21	42	57	92	234	-1	195	100	138	50	92	53
TTM Free Cash Flow to Firm	-5	9	26	25	53	76	94	245	1	199	108	156	104	112	64

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	81.91	29.18	26.56	28.38	27.3	16.45	22.11	9.94	-47.99	17.01	18.98	7.23	12.26	16.8	63.24
EV/EBIT	624.79	224.52	41.27	34.03	50.5	32.4	27	10.1	- -	51.47	15.27	330.15	109.08	73.87	71.01
Enterprise Value	159	273	660	705	1,380	1,422	1,838	1,654	816	1,049	1,586	1,003	1,071	1,701	3,351
Low Price	5.39	6.99	11.87	26.19	30.97	51.19	59.31	79.98	52.68	35.71	61.52	45.27	49.24	67.53	93.58
EV/Sales	5.28	8.69	13.47	10.92	19.19	13.05	13.03	6.58	6.79	6.42	6.57	5.11	8.16	10.18	12.5
EV/EBITDA	52.13	69.2	35.37	30.16	46.07	25.77	23.04	9.27	21.47	21.7	10.24	18.37	23.12	29.19	41.39
Price/Earnings	14.97	- -	58.36	56.36	5.82	- -	143.09	12.5	1.96	- -	28.05	- -	23.69	- -	29.38
Price/Earnings Average	14.49	-374.96	41.22	62.71	4.65	-865.63	126.36	17.29	2.1	-332.69	25.26	-31.98	22.45	-417.4	21.89
Price/Earnings High	20.5	-511.21	64.89	85.2	6.12	-1,110.46	156.02	25.66	2.73	-432.3	39.9	-49.29	28.42	-589.25	33.02
Price/Earnings Low	10.91	-263.33	21.11	44.47	2.67	-651.81	99.35	11.81	1.59	-193.62	17.91	-22.89	16.33	-306.33	14.54
Price/Book Value	-0.21	-0.38	-0.99	-1.03	-3.12	-3.06	-4.48	-7.82	3.09	2.56	3.57	2.5	2.46	3.93	6.01
Price/Book Value Average	-0.21	-0.29	-0.7	-1.14	-2.49	-3.28	-3.96	-10.81	3.31	2.53	3.21	2.37	2.33	3.37	4.48
Price/Book Value High	-0.29	-0.39	-1.1	-1.55	-3.28	-4.21	-4.89	-16.05	4.29	3.29	5.08	3.65	2.95	4.76	6.76
Price/Book Value Low	-0.16	-0.2	-0.36	-0.81	-1.43	-2.47	-3.11	-7.38	2.5	1.47	2.28	1.69	1.69	2.48	2.98
Price/Tangible Book Value	-2.33	-6.17	-32.84	-15.72	6.44	19.38	21.24	8.03	2.8	-11.62	4.88	8.1	4.15	4.27	5.3
Price/Tangible Book Value Average	-2.26	-4.74	-23.19	-17.49	5.14	20.79	18.76	11.11	3	-11.49	4.39	7.67	3.93	3.67	3.95
Price/Tangible Book Value High	-3.19	-6.47	-36.51	-23.76	6.77	26.67	23.16	16.49	3.89	-14.93	6.94	11.82	4.98	5.18	5.95
Price/Tangible Book Value Low	-1.7	-3.33	-11.88	-12.4	2.95	15.65	14.75	7.59	2.27	-6.69	3.11	5.49	2.86	2.69	2.62
Price/Sales	4.84	8.18	13.61	10.5	18.61	12.12	12.73	7.12	10.27	6.14	6.63	5.74	9.41	11.73	13.64
Price/Sales Average	4.69	6.3	9.61	11.68	14.86	13	11.24	9.85	11	6.07	5.97	5.44	8.92	10.07	10.16
Price/Sales High	6.63	8.58	15.13	15.87	19.57	16.67	13.88	14.63	14.28	7.89	9.44	8.38	11.29	14.22	15.33
Price/Sales Low	3.53	4.42	4.92	8.29	8.52	9.79	8.84	6.73	8.32	3.53	4.24	3.89	6.49	7.39	6.75
Price/Cash Flow	-124.11	1,595.65	32.21	32.95	32.08	21.74	20.28	9.23	-42.13	18.4	20.34	8.17	24.92	20.19	74.07
Price/Cash Flow Average	-120.1	1,227.35	22.75	36.66	25.61	23.32	17.91	12.77	-45.11	18.19	18.32	7.74	23.62	17.34	55.2
Price/Cash Flow High	-169.89	1,673.33	35.81	49.81	33.73	29.91	22.12	18.95	-58.55	23.64	28.93	11.93	29.9	24.48	83.25
Price/Cash Flow Low	-90.4	861.94	11.65	26	14.69	17.56	14.08	8.72	-34.11	10.59	12.98	5.54	17.18	12.73	36.66
Price/Free Cash Flow Average	79.27	22.44	18.76	31.58	21.8	17.64	19.52	13.75	-51.39	16.82	17.09	6.85	11.62	14.42	47.13
Price/Free Cash Flow High	112.13	30.6	29.53	42.9	28.71	22.63	24.11	20.41	-66.7	21.86	27	10.56	14.71	20.36	71.07
Price/Free Cash Flow Low	59.66	15.76	9.61	22.4	12.5	13.28	15.35	9.39	-38.86	9.79	12.12	4.9	8.45	10.58	31.3
EV/Sales Average	5.46	6.8	9.56	12.21	16.87	15.05	12.82	11.92	15.81	8.57	7.24	5.65	8.79	9.68	11.19
EV/Sales High	7.4	9.09	15.08	16.4	21.58	18.72	15.46	16.69	19.09	10.39	10.7	8.6	11.16	13.83	16.36
EV/Sales Low	4.3	4.93	4.87	8.81	10.53	11.84	10.42	8.79	13.13	6.03	5.5	4.11	6.36	7	7.78
EV/EBITDA Average	53.88	54.16	25.11	33.73	40.49	29.72	22.68	16.79	50.04	28.99	11.29	20.33	24.91	27.77	37.06
EV/EBITDA High	73.05	72.38	39.6	45.3	51.8	36.98	27.34	23.52	60.41	35.14	16.7	30.92	31.63	39.66	54.16
EV/EBITDA Low	42.44	39.24	12.8	24.35	25.27	23.38	18.43	12.39	41.55	20.41	8.58	14.78	18.02	20.08	25.76
EV/EBIT Average	645.69	175.72	29.29	38.05	44.38	37.37	26.58	18.3	-332.46	68.77	16.83	365.36	117.52	70.27	63.59
EV/EBIT High	875.42	234.82	46.2	51.11	56.78	46.49	32.05	25.63	-401.36	83.35	24.89	555.55	149.24	100.37	92.92
EV/EBIT Low	508.62	127.3	14.93	27.47	27.7	29.4	21.6	13.51	-276.05	48.4	12.79	265.51	85.02	50.82	44.2
Last Price	7.4	12.94	32.81	33.19	67.64	63.39	85.42	84.65	65.06	62.04	96.36	66.8	71.42	107.15	189.07
High Price	10.13	13.57	36.48	50.17	71.12	87.21	93.14	173.81	90.42	79.73	137.09	97.49	85.7	129.9	212.49
Enterprise Value Average	164	213	468	788	1,213	1,640	1,809	2,997	1,902	1,402	1,748	1,110	1,154	1,618	3,001
Enterprise Value High	222	285	738	1,059	1,552	2,040	2,182	4,197	2,296	1,699	2,585	1,687	1,466	2,311	4,386
Enterprise Value Low	129	155	239	569	757	1,290	1,470	2,212	1,579	987	1,328	806	835	1,170	2,086

Shares Outstanding	20	21	20	20	20	21	21	21	17	16	17	17	18	19	20
Diluted Weighted Avg Shares	20	20	21	21	21	21	23	24	20	16	17	17	18	18	20
Basic Weighted Avg Shares	20	20	20	20	20	21	21	21	19	16	17	17	17	18	19
Revenue per Share	1.53	1.58	2.41	3.16	3.63	5.23	6.71	11.88	6.33	10.11	14.52	11.63	7.59	9.14	13.86
EBITDA per Share	0.15	0.2	0.92	1.14	1.51	2.65	3.79	8.43	2	2.99	9.31	3.24	2.68	3.19	4.19
Operating Income per Share	0.01	0.06	0.79	1.01	1.38	2.11	3.24	7.74	-0.3	1.26	6.24	0.18	0.57	1.26	2.44
Basic EPS, GAAP	0.49	-0.03	0.56	0.59	11.61	-0.08	0.6	6.77	33.13	-0.18	3.44	-1.98	3.02	-0.22	6.44
Basic EPS from Cont Ops	0.49	-0.13	0.43	0.53	11.49	-0.11	0.6	6.77	33.13	0.41	4.59	-0.31	3.11	-0.22	6.44
Diluted EPS, GAAP	0.49	-0.03	0.55	0.56	10.83	-0.08	0.53	5.96	31.85	-0.18	3.31	-1.98	2.94	-0.22	6.13
Diluted EPS from Cont Ops	0.49	-0.13	0.43	0.51	10.71	-0.11	0.53	5.96	31.85	0.41	4.43	-0.31	3.03	-0.22	6.13
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.06	0.01	1.02	1.01	2.11	2.92	4.21	9.17	-1.54	3.37	4.74	8.17	2.87	5.31	2.55
Free Cash Flow per Basic Share	-0.21	-0.43	0.78	0.79	1.56	1.98	4.11	8.66	-1.68	3.1	4.21	7.11	-0.25	4.23	1.97
Cash & Equivalents per Share	0.87	0.62	0.79	8.2	10.12	6.77	9.59	36.57	56.32	25.41	20.51	12.56	9.85	14.55	39.11
Book Value per Share	-34.71	-34.39	-33.05	-32.29	-21.7	-20.69	-19.06	-10.83	21.06	24.22	27.01	26.73	29.08	27.28	31.45
Tangible Book Value per Share	-3.17	-2.1	-1	-2.11	10.5	3.27	4.02	10.54	23.24	-5.34	19.76	8.25	17.22	25.07	35.69

Ligand Pharmaceuticals Incorporated

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)